Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension

Completed · Phase 3

Conditions studied: Hypertension

In brief

The purpose of this study was to determine if nebivolol is superior to placebo for the treatment of elevated blood pressure in Black patients with mild to moderate hypertension.

Key facts

Study ID

NCT00145236

Run by

Mylan Bertek Pharmaceuticals

People needed

300

Starts

2001-11-01

Expected to finish

2003-08-01

Last updated by the study team

2005-09-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Black adults with an average sitting diastolic blood pressure of greater then or equal to 95 mmHg and less then or equal to 109 mmHg at baseline.

You may not qualify if…

• Recent myocardial infarction or stroke
• Contraindication to beta-blocker therapy

Where it is running

• Mylan Pharmaceuticals Inc. — Morgantown, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.